Knight Therapeutics Reports Third-Quarter 2026 Results
Knight Therapeutics said it achieved record-high revenues for the first nine months of 2026.
Related stories
TC Energy Q3 Revenue Reaches CA$4.03B
TC Energy reported Q3 revenue of CA$4.03 billion, versus a FactSet estimate of CA$3.98 billion.
M impact | EQUITY | Nov 05, 2026, 11:51 AM UTC
Himax Technologies Reports Q3 Revenue of $246.8 Million
M impact | EQUITY | Nov 05, 2026, 11:47 AM UTC
TC Energy tops quarterly profit estimates
M impact | EQUITY | Nov 05, 2026, 11:39 AM UTC
ACI Worldwide Q3 revenue tops estimates on Biller growth
ACI Worldwide reported third-quarter revenue above estimates, citing growth in its Biller segment.
M impact | EQUITY | Nov 05, 2026, 11:37 AM UTC
Zignago Vetro Reports Q3 Net Profit of EUR 3.6 Million
M impact | EQUITY | Nov 05, 2026, 11:37 AM UTC
Knight Therapeutics Q3-26 Net Loss Narrows 29% to CAD 2.68 Million
M impact | EQUITY | Nov 05, 2026, 11:36 AM UTC